{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:14:14Z","timestamp":1788430454423,"version":"build-2803163510"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neurourology and Urodynamics"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>SARS\u2010CoV\u20102 infection can result in genitourinary symptoms, such as frequency, urgency, nocturia, and pain\/pressure. In this study, we followed the progression of overactive bladder (OAB) symptoms in patients that reported new or worsening OAB symptoms after coronavirus disease\u201019 (COVID\u201019) diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>Individuals from a COVID\u201019 serology study were invited to participate in a follow\u2010up study. Respondents were divided into three groups based on prior COVID\u201019 testing. Patients scored symptoms retrospectively before the pandemic, at study onset, and prospectively during 12\u2010month follow\u2010up. Genitourinary symptoms were assessed using international consultation on incontinence questionaire for OAB (ICIQ\u2010OAB). Change in ICIQ\u2010OAB scores from baseline were calculated. The minimal important difference of one on ICIQ\u2010OAB is considered a significant change.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>26.0% of participants previously had positive COVID polymerase chain reaction (PCR) test (PCR+), 5.6% a positive serology test only (Ser+), and 65.5% were COVID na\u00efve (COVID\u2212). 23.8% of participants reported a significant increase in ICIQ\u2010OAB score at study onset compared to prepandemic. ICIQ\u2010OAB scores were similar at prepandemic but significantly higher at study start (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) in PCR+ group. During follow\u2010up, change in ICIQ\u2010OAB scores from baseline remained unchanged for COVID\u2212 group, but gradually reduced for PCR+, reaching similar levels as COVID\u2212 group by 12 months. By 12 months, 71.4% of PCR+, 42.9% of Ser+, and 68.8% of COVID\u2212 participants still reported significant increase in ICIQ\u2010OAB scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Most COVID\u201019 patients experienced return of symptoms to baseline, indicative of the potential resolution of COVID\u2010associated cystitis. A subset of cases did not, raising questions about the underlying factors contributing to this outcome. Additional research is needed to assess long COVID on urological health.<\/jats:p><\/jats:sec>","DOI":"10.1002\/nau.25509","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T10:35:54Z","timestamp":1717410954000},"page":"1514-1522","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prospective follow\u2010up of overactive bladder symptoms in patients with prior SARS\u2010CoV\u20102 infection"],"prefix":"10.1002","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7550-6305","authenticated-orcid":false,"given":"Priya","family":"Padmanabhan","sequence":"first","affiliation":[{"name":"Department of Urology Corewell Health William Beaumont University Hospital Royal Oak Michigan USA"},{"name":"Department of Urology Oakland University William Beaumont School of Medicine Rochester Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-2592","authenticated-orcid":false,"given":"Ly Hoang","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Urology, Glickman Urological and Kidney Institute Cleveland Clinic Cleveland Ohio USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-8972","authenticated-orcid":false,"given":"Michael B.","family":"Chancellor","sequence":"additional","affiliation":[{"name":"Department of Urology Corewell Health William Beaumont University Hospital Royal Oak Michigan USA"},{"name":"Department of Urology Oakland University William Beaumont School of Medicine Rochester Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9020-598X","authenticated-orcid":false,"given":"Kenneth M.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Urology Corewell Health William Beaumont University Hospital Royal Oak Michigan USA"},{"name":"Department of Urology Oakland University William Beaumont School of Medicine Rochester Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-5751","authenticated-orcid":false,"given":"Bernadette M. M.","family":"Zwaans","sequence":"additional","affiliation":[{"name":"Department of Urology Corewell Health William Beaumont University Hospital Royal Oak Michigan USA"},{"name":"Department of Urology Oakland University William Beaumont School of Medicine Rochester Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000129184.87042.FC"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030231"},{"key":"e_1_2_10_4_1","unstructured":"World Health Organization. WHO coronavirus (COVID19) dashboard. 2023. Accessed July 1 2023.https:\/\/covid19.who.int\/"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-020-01760-4"},{"issue":"11","key":"e_1_2_10_6_1","first-page":"384","article-title":"Post\u2010COVID\u201019 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved","volume":"72","author":"Carod\u2010Artal FJ","year":"2021","journal-title":"Rev Neurol"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2103077"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2020.173"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmab076"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06359-2"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.10.001"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-03030-2"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.12.043"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.01.052"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2018.03.133"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)59130-2"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.09.009"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137310"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110375"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1684"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12059"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(89)90005-6"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.05.013"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.12.020"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00846-2"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051828"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250708"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000427"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02143-7"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-016-0179-x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12018"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194341"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/nau.25509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:02:20Z","timestamp":1724292140000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.25509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1002\/nau.25509"],"URL":"https:\/\/doi.org\/10.1002\/nau.25509","archive":["Portico"],"relation":{},"ISSN":["0733-2467","1520-6777"],"issn-type":[{"value":"0733-2467","type":"print"},{"value":"1520-6777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"2024-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}